申请人:Ikeda Yutaka
公开号:US20120264923A1
公开(公告)日:2012-10-18
The present invention relates to a liquid crystal compound that can be used as a base for injection formulations. The present invention provides an amphipathic compound having the following general formula (I):
wherein X and Y each denotes a hydrogen atom or together denote an oxygen atom, n denotes an integer from 0 to 2, m denotes the integer 1 or 2, and R denotes a hydrophilic group generated by removal of one hydroxyl group from any one selected from the group consisting of glycerol, erythritol, pentaerythritol, diglycerol, triglycerol, xylose, sorbitol, ascorbic acid, glucose, galactose, mannose, dipentaerythritol, maltose, mannitol, and xylitol; as well as a base for injection formulations and depot formulation comprising the same.
本发明涉及一种可作为注射制剂基质的液晶化合物。本发明提供了一种两亲性化合物,具有如下通式(I):
其中,X和Y各自表示氢原子,或者共同表示一个氧原子,n表示从0到2的整数,m表示整数1或2,R表示由来自甘油、赤藓糖醇、季戊四醇、双甘油、三甘油、木糖、山梨糖醇、抗坏血酸、葡萄糖、半乳糖、甘露糖、双季戊四醇、麦芽糖、甘露醇和木糖醇中任选其一去除一个羟基而生成的亲水基团;以及包含该化合物的注射制剂基质和储存型制剂。